Clomiphene Citrate Stair-Step Protocol
Polycystic Ovary
About this trial
This is an interventional treatment trial for Polycystic Ovary focused on measuring clomiphene citrate, stair- step, poly cystic ovary
Eligibility Criteria
Inclusion Criteria:
Age between 20-35 years.
- Body mass index (BMI/m2) 26-35 kg/m2
- Normal hystrosalpingogram (HSG).
- Normal Prolactin level.
- Normal semen analysis.
Exclusion Criteria:
- - They underwent ovarian drilling.
- Other factors infertility.
- AUTOimmune diseases as thyroid disorders and systemic lupus erythematosus.
Sites / Locations
- Ain Shams University Maternity HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Traditional
Stair step protocol
Clomiphene citrate (50mg) will be given for 5 days (days 3-7). Transvaginal ultrasound from 9th-20th every other day if ovulation occur the patient will be excluded. If no ovulation, we will wait for the next menses and increase the dose to (100mg). if no ovulation occurred increase the dose to (150mg) in the next cycle if no ovulation increase the dose to (200mg) TVUS from 9th-20th ovary other day. If no ovulation we will wait for next cycle and increase the dose to (250mg) and so till 6 cycles.
If there is no response (no follicle >10mm), so, (100mg) clomiphene will be initiated immediately for 5 days and ultrasound will be repeated 1 week after the first ultrasound. If there is no response, (150mg) clomiphene will be initiated immediately for another 5 days and TV/US will be performed 1 week after the second TV/US